Content area

|
|

Sjögrens syndrom

Forfatter(e)

Marie Louise Næstholt Jensen1, 2, Anne Margrethe Troldborg1, 2, Mogens Pfeiffer-Jensen3 & Bent Deleuran1, 2

1) Led- og Bindevævssygdomme, Aarhus Universitetshospital, 2) Biomedicinsk Institut, Health, Aarhus Universitet, 3) Afdeling for Rygkirurgi, Led- og Bindevævsygdomme, Københavns Universitetshospital – Rigshospitalet Glostrup

Ugeskr Læger 2021;183:V04210309

Reference: 
Ugeskr Læger 2021;183:V04210309
Sjögren’s syndrome

Marie Louise Næstholt Jensen, Anne Margrethe Troldborg, Mogens Pfeiffer-Jensen & Bent Deleuran

Ugeskr Læger 2021;183:V04210309

Sjögren’s syndrome (SS) is a common autoimmune disease with a prevalence of 1%. SS affects primarily women between the age of 30 and 50 years. The classic manifestations are sicca symptoms, musculoskeletal pain and fatigue but the disease can affect all organs. SS is associated with the antibody anti-SSA antibodies. The patients have a 15-20 times higher risk of lymphoma and an increased risk of spontaneous abortion and AV-block in life-born children. In this review, we share the diagnostic process and risk stratification and outline the treatments available from private practice.

Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Kamaran Shorsh | 24/09
2 kommentarer
af Julius Vindbjerg Nissen | 24/09
4 kommentarer
af Carsten Anker Edmund | 24/09
26 kommentarer
af Helle Lone Jensen | 23/09
1 Kommentar
af Martin Gottliebsen | 21/09
2 kommentarer
af Bente Ulla Rasmusson | 20/09
1 Kommentar
af Carsten Reidies Bjarkam | 18/09
1 Kommentar